Nucleocapsid-specific antibodies as a correlate of protection against SARS-CoV-2 reinfection in children

sKIDS Investigation team

doi:10.1016/j.jinf.2023.06.018

Nucleocapsid-specific antibodies as a correlate of protection against SARS-CoV-2 reinfection in children

sKIDS Investigation team

Research output: Contribution to journal › Letter › peer-review

Original language	English
Pages (from-to)	267-269
Number of pages	3
Journal	Journal of Infection
Volume	87
Issue number	3
Early online date	28 Jun 2023
DOIs	https://doi.org/10.1016/j.jinf.2023.06.018
Publication status	Published - Sept 2023

Bibliographical note

Funding:
This study was funded by the Medical Research Council UK Coronavirus Immunology Consortium (UK-CIC, MR/V028448/1) and the National Core Studies (NCS) programme (MC_PC_20031). The funders had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.

Keywords

Child
Humans
SARS-CoV-2
Reinfection/prevention & control
COVID-19
Nucleocapsid
Antibodies, Viral
Antibodies, Neutralizing

Access to Document

10.1016/j.jinf.2023.06.018

A UK underpinning platform to study immunology and immunopathology of COVID-19:The UK Coronavirus Immunology Consortium
Duggal, N., Zuo, J., Moss, P., Long, H., Lord, J., Taylor, G. & Wraith, D.
Medical Research Council
20/08/20 → 31/10/22
Project: Research Councils

Cite this

@article{d4c510eadb1b4fc394e625ecdc8af554,

title = "Nucleocapsid-specific antibodies as a correlate of protection against SARS-CoV-2 reinfection in children",

keywords = "Child, Humans, SARS-CoV-2, Reinfection/prevention & control, COVID-19, Nucleocapsid, Antibodies, Viral, Antibodies, Neutralizing",

author = "{sKIDS Investigation team} and Dowell, {Alexander C} and Dagmar Waiblinger and John Wright and Ladhani, {Shamez N} and Paul Moss",

note = "Funding: This study was funded by the Medical Research Council UK Coronavirus Immunology Consortium (UK-CIC, MR/V028448/1) and the National Core Studies (NCS) programme (MC_PC_20031). The funders had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.",

year = "2023",

month = sep,

doi = "10.1016/j.jinf.2023.06.018",

language = "English",

volume = "87",

pages = "267--269",

journal = "Journal of Infection",

issn = "0163-4453",

publisher = "Elsevier",

number = "3",

}

TY - JOUR

T1 - Nucleocapsid-specific antibodies as a correlate of protection against SARS-CoV-2 reinfection in children

AU - sKIDS Investigation team

AU - Dowell, Alexander C

AU - Waiblinger, Dagmar

AU - Wright, John

AU - Ladhani, Shamez N

AU - Moss, Paul

N1 - Funding: This study was funded by the Medical Research Council UK Coronavirus Immunology Consortium (UK-CIC, MR/V028448/1) and the National Core Studies (NCS) programme (MC_PC_20031). The funders had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.

PY - 2023/9

Y1 - 2023/9

KW - Child

KW - Humans

KW - SARS-CoV-2

KW - Reinfection/prevention & control

KW - COVID-19

KW - Nucleocapsid

KW - Antibodies, Viral

KW - Antibodies, Neutralizing

U2 - 10.1016/j.jinf.2023.06.018

DO - 10.1016/j.jinf.2023.06.018

M3 - Letter

C2 - 37391077

SN - 0163-4453

VL - 87

SP - 267

EP - 269

JO - Journal of Infection

JF - Journal of Infection

IS - 3

ER -

Nucleocapsid-specific antibodies as a correlate of protection against SARS-CoV-2 reinfection in children

Bibliographical note

Keywords

Access to Document

Projects

A UK underpinning platform to study immunology and immunopathology of COVID-19:The UK Coronavirus Immunology Consortium

Cite this